For Biopharma, a Rising Tide—and Choppy Waters
Powerful trends are shaping a promising yet challenging decade for the industry.
Powerful trends are shaping a promising yet challenging decade for the industry.
To advance from promise to value, biopharma companies need to articulate and execute a bold vision for analytics as a fully scaled, continuously applied internal capability.
Delivering on the promise requires action on five strategic and operational tracks.
Through carve-outs, companies can create value, streamline portfolios, and reduce complexity. But the ultimate success of a deal hinges on focused, proactive execution.
An employee value proposition can help companies keep current employees and attract new ones.
As competition grows, plans need to win their members’ trust—and their renewal—every year. Here’s how to do it.
The transformation agenda for health care is government led, tailored to your country’s capabilities, and focused on better outcomes. Use this domains-and-roles framework to set your health care systems on track.
For health insurance payers, success in Medicare Advantage depends on the stars.
A global leader in prostheses, Ottobock set out to also become the ESG leader in its field. The key: measuring the socioeconomic benefit of its products.
When patients move through hospital units—and eventually are discharged—their vital information doesn’t follow. But smarter solutions can track patient data across settings.
A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.
A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.
BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Our latest edition explores the evolving landscape of business and leisure travel, examining how companies within and beyond the industry can adapt to new trends.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.